Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension. (June 2019)
- Record Type:
- Journal Article
- Title:
- Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension. (June 2019)
- Main Title:
- Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension
- Authors:
- Koo, Rachel
Lo, Jennifer
Bock, Matthew J. - Abstract:
- Abstract: Selexipag is an enteral, selective prostacyclin IP receptor agonist approved for pulmonary hypertension in adults. There are few reports of its use in children and none in infants. We report the first transition of an infant (11.5 months, 8.6 kg) from intravenous treprostinil (40 ng/kg/minute) to enteral selexipag (400 mcg twice daily) with a good response and no adverse effects.
- Is Part Of:
- Cardiology in the young. Volume 29:Number 6(2019)
- Journal:
- Cardiology in the young
- Issue:
- Volume 29:Number 6(2019)
- Issue Display:
- Volume 29, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 6
- Issue Sort Value:
- 2019-0029-0006-0000
- Page Start:
- 849
- Page End:
- 851
- Publication Date:
- 2019-06
- Subjects:
- Selexipag, -- infant, -- prostacyclin, -- pulmonary hypertension, -- paediatric
Pediatric cardiology -- Periodicals
618.9212 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=CTY ↗
- DOI:
- 10.1017/S1047951119001082 ↗
- Languages:
- English
- ISSNs:
- 1047-9511
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library STI - ELD Digital Store
- Ingest File:
- 11392.xml